| Function of macrophages in disease: current understanding on molecular mechanisms C Zhang, M Yang, AC Ericsson Frontiers in immunology 12, 620510, 2021 | 198 | 2021 |
| Current options and future directions for NAFLD and NASH treatment C Zhang, M Yang International Journal of Molecular Sciences 22 (14), 7571, 2021 | 95 | 2021 |
| Antimicrobial peptides: potential application in liver cancer C Zhang, M Yang, AC Ericsson Frontiers in microbiology 10, 1257, 2019 | 95 | 2019 |
| Antimicrobial peptides: from design to clinical application C Zhang, M Yang Antibiotics 11 (3), 349, 2022 | 93 | 2022 |
| The related metabolic diseases and treatments of obesity M Yang, S Liu, C Zhang Healthcare 10 (9), 1616, 2022 | 86 | 2022 |
| Treatment of liver fibrosis: Past, current, and future CY Zhang, S Liu, M Yang World Journal of Hepatology 15 (6), 755, 2023 | 55 | 2023 |
| The role of liver sinusoidal endothelial cells in cancer liver metastasis M Yang, C Zhang American Journal of Cancer Research 11 (5), 1845, 2021 | 55 | 2021 |
| Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria M Yang, C Zhang, MZ Zhang, S Zhang BMC microbiology 18, 1-14, 2018 | 54 | 2018 |
| Hepatocellular carcinoma and obesity, type 2 diabetes mellitus, cardiovascular disease: causing factors, molecular links, and treatment options C Zhang, S Liu, M Yang Frontiers in Endocrinology 12, 808526, 2021 | 50 | 2021 |
| The potential gut microbiota mediated treatment options for liver cancer C Zhang, M Yang, AC Ericsson Frontiers in Oncology 10, 2214, 2020 | 50 | 2020 |
| Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges M Yang, C Zhang, X Zhang, MZ Zhang, GE Rottinghaus, S Zhang BMC microbiology 16, 1-18, 2016 | 44 | 2016 |
| Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy CY Zhang, S Liu, M Yang World Journal of Hepatology 15 (2), 180, 2023 | 41 | 2023 |
| Consideration of gut microbiome in murine models of diseases C Zhang, CL Franklin, AC Ericsson Microorganisms 9 (5), 1062, 2021 | 35 | 2021 |
| G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment M Yang, CY Zhang World Journal of Gastroenterology 27 (8), 677, 2021 | 34 | 2021 |
| Cancer immunotherapy and delivery system: an update M Yang, OT Olaoba, C Zhang, ET Kimchi, KF Staveley-O’Carroll, G Li Pharmaceutics 14 (8), 1630, 2022 | 33 | 2022 |
| The emerging factors and treatment options for NAFLD-related hepatocellular carcinoma C Zhang, M Yang Cancers 13 (15), 3740, 2021 | 31 | 2021 |
| The role and potential application of antimicrobial peptides in autoimmune diseases C Zhang, M Yang Frontiers in immunology 11, 859, 2020 | 29 | 2020 |
| Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy CY Zhang, S Liu, M Yang World Journal of Gastroenterology 28 (27), 3346, 2022 | 27 | 2022 |
| Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions M Yang, C Zhang, MZ Zhang, S Zhang BMC microbiology 17, 1-14, 2017 | 27 | 2017 |
| Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options CY Zhang, S Liu, M Yang World journal of gastroenterology 28 (48), 6827, 2022 | 25 | 2022 |